not sure who Roch and what they mean to you
However for a 6 million market cap on a drug company that has around 6 million in cash including R&D rebates, drug that targets the source of brain injury exactly like AGN, GLP results that have so far proven its safety and heading into a fully funded Phase 1 study that proves that the drug is safe and the only drug in the world for both traumatic brain injury and stroke together, compared to AGN only completed phase 1 for stroke, the investment is very compelling with a significant upside coming up.
CEO James is hosting a Webinar next week on non dilutive funding after phase 1 completion hopefully you can attend and stop making lies wasting your time trying to troll on a stock you don’t own
- Forums
- ASX - By Stock
- NYR
- Ann: Brain Injury Program GLP Studies Further Update
Ann: Brain Injury Program GLP Studies Further Update, page-24
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.009(14.8%) |
Mkt cap ! $9.474M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.2¢ | $12.47K | 222.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 165000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 0.051 |
1 | 10000 | 0.050 |
1 | 100000 | 0.044 |
1 | 250020 | 0.040 |
1 | 29440 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 165000 | 1 |
0.058 | 83446 | 1 |
0.059 | 9534 | 1 |
0.061 | 150000 | 1 |
0.064 | 10000 | 1 |
Last trade - 14.05pm 26/08/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |